drugset / Trial / NCT01972919
MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
This research study is for people who have pancreas cancer for which surgery is not recommended. Potential patients must have already received several months of chemotherapy before they are eligible for this study and there will not have been any detectable spread of their tumor on imaging studies following this chemotherapy course.
Timeline
- Start
- 2015-12-10
- Primary completion
- 2023-12-13
- Completion
- 2026-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Capecitabine | Small molecule | 825 mg/m2 | Oral |
| Background | Gemcitabine | Small molecule | 400 mg/m2 | Intravenous |